Evidence map›Paper›PMID 26096614›Full record

ArticleThe Journal of physiology2015

ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.

P Imbrici, L Maggi, G F Mangiatordi, M M Dinardo, C Altamura, R Brugnoni, D Alberga, G Lauria Pinter, G Ricci, G Siciliano and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Skeletal muscle ClC-1 chloride channels in health and diseases.Pflugers Archiv : European journal of physiology · 2020
    Review
  9. Census of halide-binding sites in protein structures.Bioinformatics (Oxford, England) · 2020
    Article
  10. Divergent CleLife · 2020
    Article
  11. Review
  12. Article
  13. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

P ImbriciDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
L MaggiNeuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
G F MangiatordiDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
M M DinardoDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
C AltamuraDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
R BrugnoniNeuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
D AlbergaDepartment of Physics 'M. Merlin', INFN and TIRES, University of Bari, Bari, Italy.
G Lauria PinterNeuroalgology and Headache Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
G RicciDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
G SicilianoDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
R MicheliUnit of Child Neurology and Psychiatry, Spedali Civili, Brescia, Italy.
G AnnicchiaricoRegional Coordination for Rare Diseases, A. Re. S. Puglia, Bari, Italy.
G LattanziDepartment of Physics 'M. Merlin', INFN and TIRES, University of Bari, Bari, Italy.
O NicolottiDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
L MorandiNeuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
P BernasconiNeuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
J-F DesaphyDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
R MantegazzaNeuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico 'Carlo Besta', Milano, Italy.
D Conte CamerinoDepartment of Pharmacy - Drug Sciences, University of Bari, Bari, Italy.
University of Bari Aldo Moro · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Pisa · ITAgenzia Regionale Sanitaria della Puglia · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

Telethon GGP14096
6 · The paper itself

Abstract

key pointsLoss-of-function mutations of the skeletal muscle ClC-1 channel cause myotonia congenita with variable phenotypes. Using patch clamp we show that F484L, located in the conducting pore, probably induces mild dominant myotonia by right-shifting the slow gating of ClC-1 channel, without exerting a dominant-negative effect on the wild-type (WT) subunit. Molecular dynamics simulations suggest that F484L affects the slow gate by increasing the frequency and the stability of H-bond formation between E232 in helix F and Y578 in helix R. Three other myotonic ClC-1 mutations are shown to produce distinct effects on channel function: L198P shifts the slow gate to positive potentials, V640G reduces channel activity, while L628P displays a WT-like behaviour (electrophysiology data only). Our results provide novel insight into the molecular mechanisms underlying normal and altered ClC-1 function. ABSTRACT: Myotonia congenita is an inherited disease caused by loss-of-function mutations of the skeletal muscle ClC-1 chloride channel, characterized by impaired muscle relaxation after contraction and stiffness. In the present study, we provided an in-depth characterization of F484L, a mutation previously identified in dominant myotonia, in order to define the genotype-phenotype correlation, and to elucidate the contribution of this pore residue to the mechanisms of ClC-1 gating. Patch-clamp recordings showed that F484L reduced chloride currents at every tested potential and dramatically right-shifted the voltage dependence of slow gating, thus contributing to the mild clinical phenotype of affected heterozygote carriers. Unlike dominant mutations located at the dimer interface, no dominant-negative effect was observed when F484L mutant subunits were co-expressed with wild type. Molecular dynamics simulations further revealed that F484L affected the slow gate by increasing the frequency and stability of the H-bond formation between the pore residue E232 and the R helix residue Y578. In addition, using patch-clamp electrophysiology, we characterized three other myotonic ClC-1 mutations. We proved that the dominant L198P mutation in the channel pore also right-shifted the voltage dependence of slow gating, recapitulating mild myotonia. The recessive V640G mutant drastically reduced channel function, which probably accounts for myotonia. In contrast, the recessive L628P mutant produced currents very similar to wild type, suggesting that the occurrence of the compound truncating mutation (Q812X) or other muscle-specific mechanisms accounted for the severe symptoms observed in this family. Our results provide novel insight into the molecular mechanisms underlying normal and altered ClC-1 function.

Indexed as

AdultAgedChildChloride ChannelsFemaleGenetic Association StudiesHeterozygoteHumansIon Channel GatingMaleMiddle AgedMuscle, SkeletalMutationMyotonia CongenitaYoung AdultChloride ChannelsCLC-1 channel

Identifiers

PMID26096614
PMCPMC4594292
OpenAlexW2135221247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.